Table 3.
β by fitting of weibull distribution.
| Scale parameter | Shape parameter | Median (day) | Interquartile range | n | ||||
|---|---|---|---|---|---|---|---|---|
| Drug | α | 95%CI | β | 95%CI | 25% | 75% | ||
| Amoxicillin | 36.62 | (23.0–57.7) | 0.42 | (0.37–0.48) | 5 | 2 | 42 | 117 |
| Azithromycin | 7.45 | (6.06–9.13) | 0.54 | (0.50–0.57) | 2 | 1 | 6 | 361 |
| Ciprofloxacin | 9.07 | (6.47–12.6) | 0.6 | (0.53–0.68) | 4 | 1 | 8 | 109 |
| Clarithromycin | 10.23 | (8.56–12.2) | 0.41 | (0.40–0.43) | 2 | 1 | 7 | 810 |
| Levofloxacin | 29.13 | (20.8–40.6) | 0.41 | (0.38–0.45) | 5 | 1 | 32 | 229 |
| Moxifloxacin hydrochloride | 13.24 | (8.97–19.4) | 0.45 | (0.40–0.50) | 4 | 1 | 12 | 145 |
The calculated β was below 1, and the 95% CI did not include 1. The occurrence of these antibiotic-induced taste and smell disorders was presumed to be an early failure type that is likely to occur early.